Exhibit 107
Calculation of Filing Fee Tables
Form F-1
(Form Type)
Bionomics Limited
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | Security Type | | Security
Class
Title(1) | | Fee
Calculation
Rule | | | Amount
Registered(2) | | | Proposed
Maximum
Offering
Price Per
Unit(3) | | | Maximum
Aggregate
Offering
Price(3) | | | Fee
Rate | | | Amount of
Registration
Fee | |
| Fees to Be Paid | | Equity | | Ordinary Shares, as represented by American Depositary Shares | | | 457 | (c) | | | 233,367,480 | | | $ | 0.004361389 | | | $ | 1,017,806.33 | | | $ | 0.00014760 | | | $ | 150.23 | |
| Fees to Be Paid | | Equity | | Ordinary shares underlying the American Depositary Shares issuable upon exercise of accompanying warrants | | | 457 | (c) | | | 2,277,462,960 | | | $ | 0.004361389 | | | $ | 9,932,901.65 | | | $ | 0.00014760 | | | $ | 1,466.10 | |
| Fees to Be Paid | | Equity | | Ordinary shares underlying the American Depositary Shares issuable upon exercise of pre-funded warrants | | | 457 | (c) | | | 1,130,382,900 | | | $ | 0.004361389 | | | $ | 4,930,039.42 | | | $ | 0.00014760 | | | $ | 727.67 | |
| | | Total Offering Amounts | | | | | | | $ | 15,880,747.40 | | | | | | | $ | 2,344.00 | |
| | | Total Fee Offsets | | | | | | | | | | | | | | | $ | 0 | |
| | | Net Fee Due | | | | | | | | | | | | | | | $ | 2,344.00 | |
| (1) | American Depositary Shares, or ADSs, each representing one hundred and eighty ordinary shares, issuable upon deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 filed on December 10, 2021 (File No. 333-261582). |
| (2) | Pursuant to Rule 416 under the Securities Act of 1933, this registration statement includes an indeterminate number of additional shares that may be offered and sold to prevent dilution resulting from share splits, share dividends, recapitalizations or similar transactions. |
| | |
| (3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the average of the high and low sale prices of the registrant’s ADSs on the Nasdaq Global Market on June 13, 2024, or $0.78505, divided by 180 (to give effect to the 180:1 ratio of ordinary shares to ADSs). |
